Role of the inflammasome in insulin resistance and type 2 diabetes mellitus

Role of the inflammasome in insulin resistance and type 2 diabetes mellitus

The inflammasome is a protein complex composed of a variety of proteins in cells and which participates in the innate immune response of the body. It can be activated by upstream signal regulation and plays an important role in pyroptosis, apoptosis, inflammation, tumor regulation, etc. In recent ye...

Full description

Bibliographic Details
Main Authors:	Shen Lu, Yanrong Li, Zhaojun Qian, Tiesuo Zhao, Zhiwei Feng, Xiaogang Weng, Lili Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Immunology
Subjects:	inflammasome insulin resistance type 2 diabetes mellitus therapeutic agents NLRP3
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1052756/full

Similar Items

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
by: Yueran Cui, et al.
Published: (2022-05-01)

NLRP3 Inflammasome as a Therapeutic Target for Atherosclerosis: A Focus on Potassium Outflow
by: Yi-Jing Jin, et al.
Published: (2022-07-01)

Regulation and functions of the NLRP3 inflammasome in RNA virus infection
by: Zhaoyang Yue, et al.
Published: (2024-01-01)

Molecular Mechanisms of Inflammasome in Ischemic Stroke Pathogenesis
by: Maria Grazia Puleo, et al.
Published: (2022-09-01)

NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
by: Shaima'a Hamarsheh, et al.
Published: (2020-07-01)

Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome
by: Yu-Wei Chang, et al.
Published: (2021-02-01)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01)

Future Therapeutics: Targeting the NLRP3 Inflammasome Pathway to Manage Diabetic Retinopathy Development and Progression
by: Charisse Y. J. Kuo, et al.
Published: (2024-06-01)

The protective effect of doxofylline against lipopolysaccharides (LPS)-induced activation of NLRP3 inflammasome is mediated by SIRT1 in human pulmonary bronchial epithelial cells
by: Peng Jiao, et al.
Published: (2020-01-01)

NLPR3 Inflammasomes and Their Significance for Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2020-07-01)

Hunting down NLRP3 inflammasome: An executioner of radiation-induced injury
by: Han Cheng, et al.
Published: (2022-10-01)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
by: Yao Shen, et al.
Published: (2022-08-01)

Role of Porphyromonas gingivalis in the downregulation of NLRp3 inflammasome in periodontitis
by: Neelam Gavali, et al.
Published: (2022-01-01)

Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase
by: Wei Shi, et al.
Published: (2023-10-01)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
by: Zhang L, et al.
Published: (2022-12-01)

The role of NLRP3 inflammasome in aging and age-related diseases
by: Ruikai Liang, et al.
Published: (2024-02-01)

The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights
by: Valentina Arrè, et al.
Published: (2025-01-01)

Exercise training-attenuated insulin resistance and liver injury in elderly pre-diabetic patients correlates with NLRP3 inflammasome
by: Tan Zhang, et al.
Published: (2023-02-01)

Research advances in the regulatory mechanisms of NLRP3 inflammasome activation
by: Liu Feng, et al.
Published: (2024-06-01)

Fantastic voyage: The journey of NLRP3 inflammasome activation
by: Xiangyong Que, et al.
Published: (2024-03-01)

Rubus chingii Hu relieved the polycystic ovary syndrome with enhanced insulin sensitivity through inhibiting TXNIP/NLRP3 inflammasome signaling
by: Huizhen Li, et al.
Published: (2023-12-01)

Research Note: The effect of photoperiod on the NLRP3 inflammasome and gut microbiota in broiler chickens
by: Dandan Ma, et al.
Published: (2024-04-01)

Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
by: Wei-Ting Wong, et al.
Published: (2018-08-01)

NLRP inflammasomes in health and disease
by: Zhihao Xu, et al.
Published: (2024-04-01)

Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
by: Panagiotis Theofilis, et al.
Published: (2023-08-01)

Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo
by: Jinqian Mao, et al.
Published: (2024-05-01)

Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome Level
by: Refif Sabih Al-Shawk, et al.
Published: (2024-12-01)

NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma
by: Cong-Fa Huang, et al.
Published: (2017-09-01)

Progress of NLRP3 inflammasome in the pathogenesis of heart disease
by: GAO Yuan, ZHENG Gang, QI Jing, ZHANG Feng
Published: (2023-07-01)

Review on role of NLRP3 inflammasome in pathogenesis of silicosis
by: Zhenzhen FAN, et al.
Published: (2022-08-01)

NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns
by: Bo Wei, et al.
Published: (2024-07-01)

Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue
by: Weijie Chen, et al.
Published: (2016-10-01)

The important role of NLRP6 inflammasome in Pasteurella multocida infection
by: Xingping Wu, et al.
Published: (2022-10-01)

The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
by: Burak Ibrahim Arioz, et al.
Published: (2021-06-01)

Inflammasome genes polymorphisms and susceptibility to gout. Is there a link?
by: Denise Clavijo-Cornejo, et al.
Published: (2022-07-01)

Neuroprotection of Emodin by Inhibition of Microglial NLRP3 Inflammasome-Mediated Pyroptosis
by: Wen Jiang, et al.
Published: (2023-03-01)

Correlation of Inflammasomes with Pyroptosis and Effect on Coagulation Function
by: GAO Jiawei, et al.
Published: (2024-11-01)

Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis
by: Liu Yang, et al.
Published: (2022-12-01)

Inflammasome inhibitors: promising therapeutic approaches against cancer
by: Shengchao Xu, et al.
Published: (2019-06-01)

The NLRP3 inflammasome: contributions to inflammation-related diseases
by: Ying Chen, et al.
Published: (2023-06-01)